Workflow
Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
Globenewswire· 2026-02-06 12:00
PHocus enrollment completed in under 12 months from first patient dosed, representing a rapid enrollment pace in pulmonary hypertension associated with interstitial lung diseaseTopline results on track for second half of calendar year 2026 WALTHAM, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Pulmovant, a clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases, and a Roivant (Nasdaq: ROIV) company, today announced that it has completed enrollment in the Phase ...
AerCap Holdings N.V. Reports Record Financial Results for the Full Year 2025
Prnewswire· 2026-02-06 12:00
DUBLIN, Feb. 6, 2026 /PRNewswire/ -- AerCap Holdings N.V. (NYSE: AER), the industry leader across all areas of aviation leasing, today reported strong financial results for the fourth quarter and full year ended December 31, 2025. "We are pleased to announce another strong quarter for AerCap, completing a year of record net income and earnings per share. These results reflect a robust performance across all our business lines. During the year we sold $3.9 billion of assets for record gains on sale of $819 m ...
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
Globenewswire· 2026-02-06 12:00
IMVT-1402 potentially registrational trial in difficult-to-treat rheumatoid arthritis (D2T RA) fully enrolled, with topline data expected in the second half of calendar year 2026; topline data from the proof-of-concept trial in cutaneous lupus erythematosus (CLE) expected in the second half of calendar year 2026IMVT-1402 development is progressing with potentially registrational studies in Graves’ disease (GD), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP) and Sjögren’s di ...
Revolve Announces US$40 Million Strategic Financing With Callaway Capital
Accessnewswire· 2026-02-06 12:00
Strategic Partnership Removes Capital Constraints, Strengthens Balance Sheet, and Accelerates Advancement of 3 GW Renewable Energy Portfolio VANCOUVER, BC / ACCESS Newswire / February 6, 2026 / Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF) ("Revolve" or the "Company"), a North American owner, operator and developer of renewable energy projects, is pleased to announce that it has entered into a secured convertible credit agreement dated February 5, 2026 (the "Credit Agreement") that provides for up ...
Flotek Announces Fourth Quarter & Full Year 2025 Earnings Release and Conference Call Schedule
Prnewswire· 2026-02-06 12:00
HOUSTON, Feb. 6, 2026 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) today announced the Company's schedule for releasing its fourth quarter and full-year financial and operating results for the periods ended December 31, 2025. The Company plans to issue its fourth quarter and full-year 2025 financial and operating results press release after market close on Wednesday, March 11, 2026, and host its earnings conference call on Thursday, March 12, 2026, at 9:00 a.m. CT (10:00 a ...
Elon Musk's Mega-Merger + We Test Google's Project Genie + What's Next for Moltbook Creator
Nytimes· 2026-02-06 12:00
Core Insights - SpaceX has acquired a company named xAL, which is described as a "cash furnace," indicating its potential for generating significant revenue and profitability [1] Company Summary - SpaceX is recognized as a highly valuable and profitable company, suggesting strong financial performance and market position [1] - The acquisition of xAL may enhance SpaceX's operational capabilities and financial growth, aligning with its strategic objectives [1]
Coop Pank AS will hold an investor webinar to introduce the results for the fourth quarter and 12 month of 2025
Globenewswire· 2026-02-06 12:00
Coop Pank invites shareholders, investors, analysts and other stakeholders to join its investor webinar, scheduled on 12 February 2026 at 9:30 am (EET). The webinar will be hosted by the Chairman of the Board Arko Kurtmann and Chief Financial Officer Paavo Truu, who present the unaudited financial results of the IV quarter and the year of 2025. During the webinar all attendees can ask questions. All questions will be answered after the presentation. The webinar will be held in Estonian. To join the webinar ...
NameSilo Technologies Corp. Enters into Definitive Share Purchase Agreement to acquire Reach Systems, Inc.
Prnewswire· 2026-02-06 12:00
CSE: URL / OTC: URLOF VANCOUVER, BC, Feb. 6, 2026 /PRNewswire/ - NameSilo Technologies Corp. (CSE: URL) (PINKSHEETS: URLOF) (the "Company"), is pleased to announce that it has entered into a definitive share purchase agreement dated February 5, 2026 (the "Share Purchase Agreement") with Reach Systems, Inc. ("Reach Systems") and the shareholders of Reach Systems whereby the Company has agreed to acquire Reach Systems, which is a Canadian based engineering and manufacturing firm specializing in the design an ...
Planet Ventures Inc. Appoints Fabian Monaco to Board of Directors
TMX Newsfile· 2026-02-06 12:00
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2026) -  Planet Ventures Inc. (CSE: PXI) (OTC Pink: PNXPF) (FSE: P6U1) ("Planet" or the "Company") is pleased to announce the appointment of Fabian Monaco to its Board of Directors, effective immediately.Fabian Monaco is a highly respected technology entrepreneur, investor, and operator with a strong track record of building, scaling, and advising innovative technology businesses. He brings deep experience across venture capital, private equity, an ...
Cibus Partnering with The John Innes Centre for UK Government's Farming Innovation Programme Precision Breeding Initiative
Globenewswire· 2026-02-06 12:00
Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent years SAN DIEGO, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its participation as a key technology partner in a landmark research and development proje ...